| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.107.142257 |
| P698 | PubMed publication ID | 17413035 |
| P50 | author | Aroon Hingorani | Q47156734 |
| P2093 | author name string | David Owen | |
| Juan P Casas | |||
| Raymond J MacAllister | |||
| Simon Heales | |||
| Lila Mayahi | |||
| Joanne Harris | |||
| P433 | issue | 6 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 1334-1339 | |
| P577 | publication date | 2007-04-05 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm | |
| P478 | volume | 27 |
| Q43525134 | Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans |
| Q37385645 | Ascorbic acid and tetrahydrobiopterin potentiate the EDHF phenomenon by generating hydrogen peroxide |
| Q35060939 | Biopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice. |
| Q27329406 | Crucial role for neuronal nitric oxide synthase in early microcirculatory derangement and recipient survival following murine pancreas transplantation |
| Q34720322 | Endothelial ischemia-reperfusion injury in humans: association with age and habitual exercise |
| Q24293579 | Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling |
| Q92677852 | Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q36403729 | Prevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin |
| Q57921499 | Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men |
| Q37873087 | Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease |
| Q34252918 | Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease |
| Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
| Q34495148 | Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolemic human skin through eNOS-coupling mechanisms |
| Q41630719 | Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. |
| Q43158421 | Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury |
| Q50238440 | Tetrahydrobiopterin: a vascular redox target to improve endothelial function. |
| Q38103265 | The regulation of vascular tetrahydrobiopterin bioavailability |
| Q35978134 | Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches |
| Q37087728 | Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects |
Search more.